[Androgenetic alopecia: What's new in the last two years ?]
Centre de santé Sabouraud, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: p.reygagne@centresabouraud.fr.
P
P
Reygagne
D000505:Alopecia / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D042241:Early Diagnosis; D018120:Finasteride / Q000009:adverse effects / Q000627:therapeutic use; D005602:France; D005786:Gene Expression Regulation / Q000235:genetics; D056726:Genetic Association Studies; D005838:Genotype; D019983:Guideline Adherence; D006655:Histone Deacetylases / Q000235:genetics; D006801:Humans; D008297:Male; D008914:Minoxidil / Q000009:adverse effects / Q000627:therapeutic use; D011944:Receptors, Androgen / Q000235:genetics; D012097:Repressor Proteins / Q000235:genetics
D011944:Receptors, Androgen; D012097:Repressor Proteins; D018120:Finasteride; D008914:Minoxidil; C400300:HDAC4 protein, human; C486544:HDAC9 protein, human; D006655:Histone Deacetylases